Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
2(50%)
Results Posted
100%(1 trials)
Terminated
1(25%)

Phase Distribution

Ph not_applicable
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(1)
Terminated(1)

Detailed Status

Recruiting2
Completed1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
2
Success Rate
50.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

recruiting250%
completed125%
terminated125%

Recent Activity

2 active trials
Showing 4 of 4
terminatednot_applicable

Flexibility, Alcohol Misuse, and Excitation

NCT06634771
recruitingnot_applicable

Delirium Treatment With Transcranial Electrical Stimulation

NCT06285721
recruitingnot_applicable

Parkinson's Disease and Gamma-transcranial Alternating Current Stimulation

NCT06297538
completednot_applicable

Sleep as a Model to Understand and Manipulate Cortical Activity in Order to Promote Functional Recovery After Stroke

NCT03090711

Clinical Trials (4)

Showing 4 of 4 trials
NCT06634771Not Applicable

Flexibility, Alcohol Misuse, and Excitation

Terminated
NCT06285721Not Applicable

Delirium Treatment With Transcranial Electrical Stimulation

Recruiting
NCT06297538Not Applicable

Parkinson's Disease and Gamma-transcranial Alternating Current Stimulation

Recruiting
NCT03090711Not Applicable

Sleep as a Model to Understand and Manipulate Cortical Activity in Order to Promote Functional Recovery After Stroke

Completed

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4